Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 220

IVF technology matures eggs in a culture of iPSC (induced stem cell)-derived ovarian cells.

A baby was born in their trial, marking “first ever human birth using using iPSC technology” company claims.

Gameto useds iPSCs, or induced pluripotent stem cells. Same as embryonic stem cell, except made by inducing (forcing) a skin cell or white blood from a donor cell to become a stem cell using a protein cocktail. Dont need embryo to start.

This is also the first demonstration of an end-to-end process by which a therapy developed from induced pluripotent stem cells (iPSC) has the potential to improve IVF outcomes and advance women’s health. Co-culturing immature eggs with Gameto’s proprietary OSCs has shown promising results to date, with the potential for higher rates of egg maturation and embryo formation.

Continue reading “Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body” | >

A China-based firm has launched a novel energy storage device that tackles the 18650-battery power challenge. Introduced by Ampace, the latest JP30 cylindrical lithium battery is claimed to be capable of delivering breakthrough performance in a compact form.

Themed “Working Non-stop, compact and more powerful”, the new battery is the latest addition to the JP series.

Despite having a compact and sleek design in appearance, the battery offers ultra-high power performance.

Read more | >

Oral immunotherapy shrinks gastrointestinal tumors in mouse study.

Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success in gastrointestinal cancers. Now, researchers at Washington University School of Medicine in St. Louis have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers.

The probiotic cancer treatment, described Nov. 20 in the journal Cell Chemical Biology, establishes a customizable drug delivery system that can be modified to potentially treat other gut diseases.

Read more | >

DeepMind’s Vice President of Drastic Research and Gemini co-tech lead Oriol Vinyals describes how artificial intelligence is moving from narrowly focused systems toward autonomous agents, and what challenges remain ahead.

Ad.

According to Vinyals, AI is going through a fundamental transformation away from highly specialized systems and toward autonomous agents. Speaking on a company podcast, he explained that early AI systems like AlphaStar, which focused on playing StarCraft, were just the beginning of this development.

Read more | >

Infectious diseases can have very different effects on different people; some individuals may have virtually no symptoms from COVID-19, for example, while others are killed by the viral disease. Scientists have now learned more about one genetic mechanism that can lead to variations in immune responses in different people. The findings, which have been reported in Cell, describe a kind of tuner that can dial the immune response up or down, and has been encoded in human DNA for millions of years.

The human genome contains bits of ancient viruses known as retrotransposons, which were once able to move around the genome, like so-called jumping genes, but have since been brought under control. They are thought to compose a major part of the genome. Researchers have identified instances where retrotransposons can become active again, however, such as in some types of cancer. Now even more consequences of these trasnposons are being identified.

Read more | >

Dr. Ariel Zeleznikow-Johnston hopes to pick up the movement where Jones left off, albeit with the significant twist that his version does not require freezing. A research fellow at Melbourne’s Monash University, Zeleznikow-Johnston wrote the new book, “The Future Loves You: How and Why We Should Abolish Death,” which makes the case that cryopreservation is possible and should be more widely available. Rejecting the popular notion that death endows life with meaning as “palliative philosophy,” Zeleznikow-Johnston’s book instead argues a human’s connectome — a high-resolution map of all their brain connections — could be theoretically recorded perfectly before they die.

Once that happens, that same internal brain activity could be recreated through high-powered computers, while a new brain is grown in a vat via stem cells or some combination of the two. As such, Zeleznikow-Johnston is proposing a spiritual descendant to the cryonics movement (which he dismisses as “unscientific” and “unsubstantiated”), one where the focus is not on preserving tissues but on the “data,” so to speak, of our distinct connectomes.

“We have very strong evidence that the static structure of the neurons is enough to hold onto someone’s memories and personality.”

Read more | >

Google’s latest quantum computer chip, which the team dubbed Willow, has ignited a heated debate in the scientific community over the existence of parallel universes.

Following an eye-opening achievement in computational problem-solving, claims have surfaced that the chip’s success aligns with the theory of a multiverse, a concept that suggests our universe is one of many coexisting in parallel dimensions. In this piece, we’ll examine both sides of this argument that seems to have opened up a parallel universe of its own — with one universe of scientists suggesting the Willow experiments offer evidence of a multiverse and the other suggesting it has nothing to do with the theory at all.

According to Google, Willow solved a computational problem in under five minutes — a task that would have taken the world’s fastest supercomputers approximately 10 septillion years. This staggering feat, announced in a blog post and accompanied by a study in the journal Nature, demonstrates the extraordinary potential of quantum computing to tackle problems once thought unsolvable within a human timeframe.

Read more | >